Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 42 (TMEM42) is a protein-coding gene located on chromosome 3 in humans. It encodes a predicted integral membrane protein with 159 amino acids. The subcellular localization is suggested to be the membrane, but its molecular function and biological roles remain uncharacterized, with no direct experimental evidence for involvement in biological processes or molecular functions. TMEM42 has been associated via gene-based studies with several syndromes and disorders, including bone and developmental diseases, but the functional or causal role in these conditions has not been established. No drugs are currently reported to interact with TMEM42, and it is classified as "Tdark," indicating it is poorly characterized with limited functional data or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 42 (TMEM42).